Mefloquine
- Level
- Commodity
- Parent
- 51101900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101902This classification denotes an antimalarial agent with the molecular formula C17H16F6N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TML814419R, chemically known as 4-quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, (r*,s*)-(.+/-.)- but generally known as mefloquine, which bears US NIH Compound Identifier 4046. European Medicines Agency schedules Mefloquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08709MIG. The term MEFLOQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules mefloquine in its Anatomical Therapeutic Chemical (ATC) Classification. MEFLOQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mefloquine under HS 29334990 and SITC 51575. As of Q4 2014, MEFLOQUINE remains the US FDA Preferred Term for this commodity. Mefloquine bears US NLM identifiers UMLS ID C0025153 and NCI Concept Code C61827. SMILES: FC(F)(F)C1NC2C(C(C(O)C3NCCCC3)C1)CCCC2C(F)(F)F.
Same parent
Under 51101900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.